Gabriel Vargas, MD, PhD’s Post

Recruitment challenges in rare neurological clinical studies can cause delays to study start-up and hinder the advancement of treatments. Join us to understand the specific hurdles faced in recruiting participants for such studies and learn effective strategies to overcome them. By understanding the intricacies of rare neurological disorders and the unique circumstances surrounding their study recruitment, researchers can implement targeted approaches to reduce site start-up time and optimize recruitment strategies. https://lnkd.in/gxq8kMfK

CEEVs, Neurovascular Coupling, and Functional Connectivity Are Potential Markers For Mild Cognitive Impairment: The authors note this is the first study to assess cerebrovascular endothelial extracellular vesicles within a cognitive condition. #finance #pharmacy #lifesciences

Ethical considerations in neuromodulation: As we advance in brain stimulation therapies for Parkinson's disease, important ethical questions arise. Our recent paper discusses the implications of cognitive enhancement and equitable access to these innovative treatments. What ethical challenges do you foresee as neuromodulation technologies become more widespread? How can we address these proactively? Join the discussion and read our full analysis: https://lnkd.in/dmKm45VQ #Neuroethics #HealthcareEquity #MedicalEthics

Neuromodulation for cognitive enhancement in Parkinson's disease raises intriguing possibilities and ethical questions. Our research examines the potential benefits and considerations of using these technologies to boost cognitive function. Where do you stand on the use of neuromodulation for cognitive enhancement? What guidelines should be in place? Join the conversation and read our in-depth analysis: https://lnkd.in/dmKm45VQ #CognitiveEnhancement #Neuroethics #BrainHealth

An important challenge in epilepsy is to define biomarkers of response to treatment. Here, we use the Fractal Dimension (FD), a measure of whole brain signal complexity, to measure the response to anti-seizure therapy in patients with Focal Epilepsy (FE) and compare it with linear methods.

We know ketamine therapy works, but exactly HOW does it work? 🤔 New research reveals the science behind ketamine's impact on brain activity and its antidepressant effects. Learn how ketamine blocks NMDA receptors and alters brain wave patterns 🧠 https://lnkd.in/et-Hm52x #KetamineResearch #KetamineTherapy #MentalHealth #DepressionTreatment

#centralnervoussystem #Lin28 #neuralregeneration Lin28 as a therapeutic target for central nervous system regeneration and repair https://lnkd.in/gpAGPhXK Temple University - Lewis Katz School of Medicine

Learn more https://lnkd.in/etwcRUKj Essential tremor is the most common movement disorder in the world.1 Deep brain stimulation (DBS) therapy can help by reducing tremor and increasing the ability to perform everyday activities.2                                                                                                                                             See safety information: https://bit.ly/etam24-isi 1. Essential Tremor: Essential Facts for Patients. International Parkinson’s and Movement Disorder Society. https://lnkd.in/ef7AX7sp. 2. Medtronic DBS therapy for Parkinson's disease and essential tremor clinical summary, 2015.

New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosis #waronms #waronmsfoundation #ms #multiplesclerosis @ToNY__411 @waronms @peepswithms

Recruitment challenges in rare neurological studies can cause delays to study start-up and hinder the advancement of critical treatments. Join our experts as they discuss how to overcome these challenges and more.